Loperamide Dosing
For acute diarrhea in adults, start with 4 mg (two capsules) initially, followed by 2 mg after each unformed stool, not exceeding 16 mg (eight capsules) in 24 hours. 1
Adult Dosing Regimens
Acute Diarrhea
- Initial dose: 4 mg (two capsules)
- Maintenance: 2 mg after each loose stool
- Maximum daily dose: 16 mg (eight capsules per day)
- Expected response: Clinical improvement typically within 48 hours 1
The 2017 travelers' diarrhea guidelines confirm this same dosing: 4 mg first dose, then 2 mg after each loose stool, not to exceed 16 mg in 24 hours 2. This represents the standard of care across both FDA labeling and expert consensus.
Chronic Diarrhea
- Initial approach: Same as acute (4 mg, then 2 mg after each unformed stool)
- Maintenance: Once controlled, reduce to individual requirements
- Average maintenance: 4-8 mg daily (can be given as single or divided doses)
- Maximum: 16 mg daily
- Trial period: If no improvement after 10 days at 16 mg/day, further treatment unlikely to help 1
Pediatric Dosing (Ages 2-12 Years)
Loperamide is contraindicated in children under 2 years due to risks of respiratory depression and cardiac adverse reactions 1. For children 2-5 years (≤20 kg), use liquid formulation only.
First Day Dosing:
- Ages 2-5 years (13-20 kg): 1 mg three times daily (3 mg total)
- Ages 6-8 years (20-30 kg): 2 mg twice daily (4 mg total)
- Ages 8-12 years (>30 kg): 2 mg three times daily (6 mg total)
Subsequent Days:
- Give 1 mg per 10 kg body weight only after a loose stool
- Do not exceed first day total dosage 1
Critical Timing Considerations
Counsel patients that loperamide takes 1-2 hours to reach therapeutic effect—additional dosing should be spaced accordingly to avoid rebound constipation 2. This is a common pitfall where patients overdose trying to achieve immediate relief.
Special Populations
Elderly
- No dose adjustment required based on pharmacokinetics 1
- However, avoid in elderly patients taking QT-prolonging drugs (Class IA or III antiarrhythmics) or those with risk factors for Torsades de Pointes 1
Renal Impairment
- No dose adjustment needed (drug mainly excreted in feces) 1
Hepatic Impairment
- Use with caution—systemic exposure may increase due to reduced metabolism 1
- No specific dosing guidelines available
Absolute Contraindications
Stop loperamide immediately and do not use if:
- High fever develops
- Blood appears in stool (dysentery)
- Symptoms worsen or persist beyond initial treatment
- Clinical suspicion for invasive pathogens (Campylobacter, Salmonella, Shigella) 2
The 2017 guidelines emphasize that continued use of loperamide in the face of worsening symptoms or development of dysentery is cautioned 2. In these scenarios, antibiotics (particularly azithromycin) become necessary.
Combination Therapy
When combined with antibiotics for travelers' diarrhea, use the same loperamide dosing (4 mg initial, then 2 mg after each loose stool, max 16 mg/24h) 2. Research shows combination therapy with rifaximin reduced median time to last unformed stool to 27 hours versus 69 hours with loperamide alone 3.
Safety Warning
Never exceed 16 mg in 24 hours—higher doses risk serious cardiac adverse reactions including QT prolongation, QRS widening, and potentially fatal dysrhythmias like Torsades de Pointes 1, 4. Recent case reports document respiratory depression with high-dose use, particularly in patients with compromised gastrointestinal mucosa 5.